organophosphonates has been researched along with Adenocarcinoma in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aktaş, Y; Bilensoy, E; Sandler, N; Varan, C; Wickström, H | 1 |
| Bhatnagar, I; Chinthaparthi, RR; Cirandur, SR; Gangireddy, CS; Syama, SC | 1 |
| Abdul Salam, AA; Das, S; Kamath, PR; Rao, BS; Sunil, D | 1 |
| Basile, U; Iorio, R; Lauriola, L; Mirabella, M; Ricci, E; Sabatelli, M; Tartaglione, R; Tasca, G | 1 |
| Bauman, A; Benson, AB; Blough, RR; Carroll, RB; French, SL; Kilton, LJ; Mullane, MR; Schilsky, RL; Wade, JL | 1 |
| Ahmann, F; Blumenstein, B; Craig, JB; Crawford, ED; Eisenberger, M; Marshall, ME; Thompson, IM | 1 |
| Alberts, DS; Craig, JB; Liu, PY; Malviya, VK; O'Sullivan, J; O'Toole, R; Rosenoff, S; Surwit, E; Ward, JH; Yu, A | 1 |
| Brown, TD; Craig, JB; Einstein, AB; Fleming, T; Goodman, PJ; Macdonald, JS | 1 |
| Adams, GL; Dutcher, JP; Leaf, AN; Neuberg, D; Ritch, PS; Schwartz, EL; Wadler, S | 1 |
| Berger, MR; Galeano, A; Keppler, BK | 1 |
| Abbruzzese, JL; Ajani, JA; Bradof, JE; Daugherty, K; Levin, B; Linke, K; Pazdur, R; Winn, R | 1 |
| Berger, MZ; Dimaggio, JJ; Gralla, RJ; Heelan, RT; Kris, MG; Marks, LD; Potanovich, LM | 1 |
| Comis, RL; Hudes, GR; O'Dwyer, PJ; Ozols, RF; Paul, AR; Walczak, J | 1 |
| Henkin, RE; Quinn, JL; Thrupkaew, AK | 1 |
| Nolan, NG | 1 |
| Edeling, CJ | 1 |
| Castronovo, FP; Pendergrass, HP; Potsaid, MS | 1 |
| Struck, RF | 1 |
7 trial(s) available for organophosphonates and Adenocarcinoma
| Article | Year |
|---|---|
Phase II study of amonafide in gastric adenocarcinoma. An Illinois Cancer Center trial.
Topics: Adenine; Adenocarcinoma; Antineoplastic Agents; Female; Hematologic Diseases; Humans; Imides; Isoquinolines; Male; Naphthalimides; Organophosphonates; Stomach Neoplasms | 1994 |
Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.
Topics: Adenine; Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Administration Schedule; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Neoplasms, Hormone-Dependent; Organophosphonates; Prostatic Neoplasms; Remission Induction | 1994 |
Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group study.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Endometrial Neoplasms; Female; Humans; Imides; Intercalating Agents; Isoquinolines; Middle Aged; Naphthalimides; Neoplasm Recurrence, Local; Organophosphonates; Survival Analysis; Treatment Outcome | 1994 |
Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group study.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates | 1993 |
An ECOG phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Eastern Cooperative Oncology Group.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates | 1997 |
Phase II study of amonafide in advanced pancreatic adenocarcinoma.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates; Pancreatic Neoplasms | 1991 |
Phase II study of amonafide (nafidamide, NSC 308847) in advanced colorectal cancer.
Topics: Adenine; Adenocarcinoma; Antineoplastic Agents; Colorectal Neoplasms; Drug Evaluation; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Organophosphonates | 1991 |
11 other study(ies) available for organophosphonates and Adenocarcinoma
| Article | Year |
|---|---|
Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration.
Topics: Adenocarcinoma; Administration, Intravaginal; Antiviral Agents; Cell Line, Tumor; Cervix Uteri; Cidofovir; Cyclodextrins; Cytosine; Drug Delivery Systems; Female; Humans; Nanoparticles; Organophosphonates; Paclitaxel; Printing; Solubility; Uterine Cervical Neoplasms | 2017 |
Green synthesis of α-aminophosphonate derivatives on a solid supported TiO2 -SiO2 catalyst and their anticancer activity.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Female; Green Chemistry Technology; HeLa Cells; Humans; Organophosphonates; Silicon Dioxide; Structure-Activity Relationship; Titanium | 2013 |
Efficient T3P
Topics: Adenocarcinoma; Anhydrides; Antineoplastic Agents; Apoptosis; bcl-X Protein; Breast Neoplasms; DNA Fragmentation; Female; G1 Phase Cell Cycle Checkpoints; Green Chemistry Technology; Humans; Indoles; Ligands; MCF-7 Cells; Molecular Docking Simulation; Organophosphonates; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship; Thiadiazoles; Triazoles | 2017 |
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia.
Topics: Adenocarcinoma; Agammaglobulinemia; Aged; Antiviral Agents; Brain; Brain Neoplasms; Cidofovir; Cytosine; Diagnosis, Differential; Fatal Outcome; Heavy Chain Disease; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Organophosphonates; Paraneoplastic Syndromes; Rectal Neoplasms; Risk Factors; Virus Activation | 2009 |
Activity of two platinum-linked phosphonic acids against autochthonous rat colorectal cancer as well as in two human colon-cancer cell lines.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Humans; Male; Organophosphonates; Organophosphorus Compounds; Organoplatinum Compounds; Rats; Rats, Inbred Lew; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1992 |
Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer.
Topics: Adenine; Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Drug Tolerance; Female; Humans; Imides; Intercalating Agents; Isoquinolines; Lung Neoplasms; Male; Middle Aged; Naphthalimides; Neoplasm Staging; Organophosphonates; Remission Induction | 1991 |
False negative bone scans in disseminated metastatic disease.
Topics: Adenocarcinoma; Aged; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Carcinoma; False Negative Reactions; Female; Fluorine; Humans; Lumbar Vertebrae; Male; Middle Aged; Neoplasm Metastasis; Organophosphonates; Pelvis; Prostatic Neoplasms; Radiography; Radioisotopes; Radionuclide Imaging; Ribs; Technetium; Thoracic Vertebrae | 1974 |
Intense uptake of 99mTc-diphosphonate by an extraosseous neurofibroma.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Humans; Male; Neoplasm Metastasis; Neurofibroma; Organophosphonates; Peripheral Nervous System Neoplasms; Prostatic Neoplasms; Radionuclide Imaging; Sciatic Nerve; Technetium | 1974 |
Bone scintigraphy with 99mTc-labelled polyphosphate.
Topics: Adenocarcinoma; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Female; Fibrous Dysplasia of Bone; Hodgkin Disease; Humans; Injections, Intravenous; Kidney Failure, Chronic; Kidney Neoplasms; Kidney Transplantation; Lung Neoplasms; Male; Neoplasm Metastasis; Organophosphonates; Organophosphorus Compounds; Osteitis Deformans; Phosphates; Prostatic Neoplasms; Radionuclide Imaging; Spinal Neoplasms; Technetium | 1974 |
Effects of radiation therapy on bone lesions as measured by 99m Tc-diphosphonate.
Topics: Adenocarcinoma; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Organophosphonates; Radionuclide Imaging; Ribs; Spinal Neoplasms; Technetium; Thoracic Neoplasms | 1973 |
Synthesis of potential antineoplastic agents. 35. Phosphorus-containing structural analogs of myleran.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Busulfan; Carcinoma 256, Walker; Chemistry, Organic; Leukemia L1210; Mice; Organic Chemistry Phenomena; Organophosphonates; Sarcoma 180 | 1966 |